ArticleFrontiers in oncology2023

Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study.

Xiangling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.